Delaware Institute for Reproductive Medicine, PA

Newark, Delaware 19713

Medical Director: Jeffrey B. Russell, MD

Delaware Institute for Reproductive Medicine, PA, located in Newark, Delaware, offers comprehensive fertility care under the guidance of Medical Director Jeffrey B. Russell, MD. The clinic provides essential services including IVF, egg freezing, donor egg programs, and surrogacy support to help you build the family you've been hoping for. With a verified lab accreditation, you can trust that your care meets the highest industry standards.

Understanding success rates can help you make informed decisions about your fertility journey. For patients under 35, the clinic reports a live birth rate of 37.20%, while those ages 35-37 see a 26.00% live birth rate. In 2022, the clinic completed 511 treatment cycles, reflecting their experience in helping families navigate fertility challenges. When you're feeling overwhelmed by options and statistics, it's helpful to know that this established practice combines medical expertise with a range of treatment approaches tailored to different family-building needs.

Services Offered

IVF

In vitro fertilization — eggs are retrieved and fertilized in a lab, then transferred to the uterus.

Egg Freezing

Oocyte cryopreservation — eggs are retrieved and frozen for future use.

Donor Egg

Uses eggs from a screened donor for patients who cannot use their own.

Surrogacy

Gestational carrier arrangements — an embryo is transferred to a surrogate who carries the pregnancy.

Success Rates

Success rates reflect live births per intended egg retrieval, as reported to the CDC for the 2022 reporting year. Rates vary based on individual patient factors.

Age GroupFresh TransfersFrozen TransfersNat'l Avg
Under 3537.20%-11.231.10%48.4%
35–3726.00%-10.034.20%36%
38–4011.40%-12.2Not reported23.6%
Over 40Not reportedNot reported9.5%

Based on 511 total cycles reported. National averages computed across all reporting clinics.

Nearby Clinics

Data on this page is sourced from the CDC's National ART Surveillance System (NASS) and the Society for Assisted Reproductive Technology (SART). Success rates reflect live births per intended egg retrieval for the 2022 reporting year. Individual results vary based on patient age, diagnosis, and treatment protocol.